secwatch.observer — SEC 8-K summary
======================================

Issuer:     LeonaBio, Inc. (LONA)
CIK:        0001620463
Form:       8-K
Filed at:   2025-06-02T23:59:59+00:00
Accession:  0000950170-25-080234
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Athira shareholders approve reverse stock split at 2025 annual meeting
----------------------------------------------------------------------

- All three Class II director nominees elected: Joseph Edelman, John M. Fluke Jr., Grant Pickering.
- Ratification of Ernst & Young as independent auditor approved (26,981,568 for).
- Proposal to authorize reverse stock split approved (21,915,867 for, 4,835,818 against).
- Board may set final split ratio from 5:1 to 20:1 in its discretion.
- Quorum of 71.58% of shares present at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1620463/000095017025080234/0000950170-25-080234-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1620463/000095017025080234/atha-20250529.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-080234

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer